LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Warehouse & Storage Businesses for Sale
Environmental Businesses for Sale
Childcare & Educational Businesses for Sale
Liquor Store Businesses for Sale
Printing, Signs & Publishing Businesses for Sale
Advertising & Promotional Businesses for Sale
Post Office Businesses for Sale
Transport & Shipping Businesses for Sale
Dollar Stores for Sale
Pet Businesses for Sale
Advertising & Promotional Franchises for Sale
Retail Franchise Opportunities
Clothing & Shoe Store Franchise Opportunities
Gas Station & Car Wash Franchises for Sale
Child Care & Education Franchise Opportunities
Home Based Franchise Opportunities
Wholesale & Distribution Franchise Opportunities
Finance & Accounting Franchise Opportunities
Post Office Franchises for Sale
Liquor Franchises for Sale
Mixed Use Buildings for Sale or Rent
Land & Developments for Sale
Retail Spaces for Lease or Sale
Office Buildings for Sale or Rent
Medical Buildings for Sale or Lease
Places of Worship for Sale
Industrial Units for Sale or Rent
Commercial Buildings for Sale or Lease
Commercial Spaces for Sale or Lease
Miscellaneous Properties for Sale or Lease
An email will be sent to registered email address.
Please select if you are: